Kynos Therapeutics announces positive top-line results from
https://www.globenewswire.com/news-release/2024/04/22/2866623/0/en/Kynos-Therapeutics-announces-positive-top-line-results-from-the-first-in-human-Phase-I-study-of-its-KMO-inhibitor-KNS366-demonstrating-safety-tolerability-and-target-engagement.html
WEB2 days ago · EDINBURGH, United Kingdom, April 22, 2024 (GLOBE NEWSWIRE) -- Kynos Therapeutics Ltd, a clinical-stage biotechnology company developing first-in-class small molecule kynurenine 3-monooxygenase ...
DA: 70 PA: 15 MOZ Rank: 53